Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Therapeutic Innovation & Regulatory Science|June 30, 2026
Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research ContextDaniele Napolitano, Mattia Bozzetti, Rosario Caruso, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 11, 2025
Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: A propensity score-matched studyAlfredo Papa, Lucrezia Laterza, Valerio Papa, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 11, 2018
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" studyAnna Chiara Piscaglia, Loris Riccardo Lopetuso, Lucrezia Laterza, et al.International Journal of Molecular Sciences|September 29, 2018
Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's DiseaseEleonora Gaetani, Fabio Del Zompo, Margherita Marcantoni, et al.Alimentary Pharmacology & Therapeutics|November 18, 2024
Review Article: Green Management of IBD-New Paradigms for an Eco-Friendly ApproachGiovanni Cammarota, Lucrezia Laterza, Stefano Bibbò, et al.International Journal of Molecular Sciences|March 28, 2024
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle TogetherRossella Maresca, Irene Mignini, Simone Varca, et al.Biomedicines|June 27, 2024
Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel DiseaseValentin Calvez, Guia Becherucci, Carlo Covello, et al.World Journal of Gastroenterology|October 11, 2012
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseasesGiuseppe Merra, Giovanni Gasbarrini, Lucrezia Laterza, et al.Cancers|March 13, 2025
Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World DataPierluigi Puca, Angelo Del Gaudio, Jacopo Iaccarino, et al.Minerva Gastroenterology|January 9, 2026
Mirikizumab effectiveness in a pregnant woman with acute severe ulcerative colitis: a case reportMarco Murgiano, Angelo Del Gaudio, Pierluigi Puca, et al.Pageof 8